KRas G12R Inhibitor 1 (compound 3) is a selective covalent inhibitor targeting the KRas G12R mutation, leveraging the high nucleophilicity of mutant cysteines to bind irreversibly within the K-Ras Switch II region. This compound is utilized in cancer res
Molecular Weight:
903.2
Formula:
C39H38ClF7N6O9
* VAT and and shipping costs not included. Errors and price changes excepted